TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32330433

Group type: EXPERIMENTAL
Intervention: Prednisolone (1mg/kg/day for 24 weeks, tapering from week 9)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32195959

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with tamsulosin hydrochloride sustained-release capsule
Number of subjects: 166

Group type: COMPARATOR
Intervention: Conventional drug treatment (control)
Number of subjects: 166
Study: 35152055

Group type: EXPERIMENTAL
Intervention: External representation (computer)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal representation (mental)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First solving a problem mentally
Number of subjects: 0
Study: 34836280

Group type: EXPERIMENTAL
Intervention: Pre-operative protein caloric restriction (PCR) diet (30% calorie, 70% protein restriction) for four days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Regular ad-libitum diet
Number of subjects: 19
Study: 32517654

Group type: EXPERIMENTAL
Intervention: Protein supplementation (PRO) during endurance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CON) without protein supplementation
Number of subjects: 0
Study: 34274496

Group type: EXPERIMENTAL
Intervention: Personalized antiplatelet therapy based on CYP2C19 genotype and urine 11‐dhTxB2 tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 34553654

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (ICBT)
Number of subjects: 32
Study: 34621052

Group type: EXPERIMENTAL
Intervention: Aramchol 600 mg
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Aramchol 400 mg
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 32841941

Group type: EXPERIMENTAL
Intervention: Amoxicillin dosing regimens (100 mg/kg q12, 60/30 mg/kg q12/8, 50 mg/kg q12/8/6, 50 mg/kg q12/8/4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amoxicillin dosing regimens
Number of subjects: 0
Study: 34162239

Group type: EXPERIMENTAL
Intervention: Black older adult cancer survivors
Number of subjects: 321

Group type: COMPARATOR
Intervention: White older adult cancer survivors
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Functional difficulties (for both groups)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Cancer-related factors (for Black survivors)
Number of subjects: 321
Study: 34091741

Group type: EXPERIMENTAL
Intervention: Bladder neck and supramontanal sparing ejaculatory preserving transurethral bipolar resection of prostate (ep‐TUBRP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classic transurethral bipolar resection of prostate (c‐TUBRP)
Number of subjects: 60
Study: 35961662

Group type: EXPERIMENTAL
Intervention: Permacol (cross-linked)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Strattice (not cross-linked)
Number of subjects: 94
Study: 33721059

Group type: EXPERIMENTAL
Intervention: Strength training (three different modalities)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 128
Study: 32622626

Group type: EXPERIMENTAL
Intervention: NURD score
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: NURD score (adjusted for case-mix differences)
Number of subjects: 382
Study: 36199064

Group type: EXPERIMENTAL
Intervention: Metformin combined with dulaglutide (MET-DUL group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metformin monotherapy (MET group)
Number of subjects: 60
Study: 33449519

Group type: EXPERIMENTAL
Intervention: Fat-adaptation diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Balanced carbohydrate diet
Number of subjects: 9
Study: 32060972

Group type: EXPERIMENTAL
Intervention: 1/6 of total daily dose
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 1/8 of total daily dose
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 1/12 of total daily dose
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (usual breakthrough dose)
Number of subjects: 85
Study: 35701548

Group type: EXPERIMENTAL
Intervention: 94% ABV alcohol (males: 1.0 ml/kg; females: 0.85 ml/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34199913

Group type: EXPERIMENTAL
Intervention: Preoperative telerehabilitation (PT) program
Number of subjects: 60
Study: 32168305

Group type: EXPERIMENTAL
Intervention: Hypothermia plus melatonin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Hypothermia plus placebo
Number of subjects: 25
Study: 36348358

Group type: EXPERIMENTAL
Intervention: MBC2 diet and activity intervention
Number of subjects: 350

Group type: COMPARATOR
Intervention: Active control condition (stress and sleep management)
Number of subjects: 350
Study: 34232171

Group type: EXPERIMENTAL
Intervention: IVR training (n=10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No further training (control group, n=9)
Number of subjects: 19
Study: 32727577

Group type: EXPERIMENTAL
Intervention: esaxerenone 2.5 mg with amlodipine 10 mg/day (Study 1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: esaxerenone 5 mg/day with amlodipine 2.5 mg (Study 2)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: esaxerenone 5 mg/day with digoxin 0.25 mg/day (Study 3)
Number of subjects: 64
Study: 36072776

Group type: COMPARATOR
Intervention: Progesterone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Progesterone combined with Vitamin B6
Number of subjects: 120
Study: 33837943

Group type: EXPERIMENTAL
Intervention: 50% of landfill leachate (LL) dose plus irrigation water (IW)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 200% of landfill leachate (LL) dose plus irrigation water (IW)
Number of subjects: 5

Group type: COMPARATOR
Intervention: 0% of landfill leachate (LL) dose plus irrigation water (IW)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 100% of landfill leachate (LL) dose plus irrigation water (IW)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 150% of landfill leachate (LL) dose plus irrigation water (IW)
Number of subjects: 5
Study: 36232203

Group type: EXPERIMENTAL
Intervention: Pilates training (PT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Balance training (BT)
Number of subjects: 51
Study: 32621487

Group type: EXPERIMENTAL
Intervention: Severe anemia
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Anemia of chronic diseases (ACD)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Iron deficiency (ID)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Elevated iron
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Severe anemia and elevated iron concentrations
Number of subjects: 570
Study: 36087576

Group type: EXPERIMENTAL
Intervention: Morning loaded calorie intake (45%:35%:20% calories at breakfast, lunch, and dinner)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Evening loaded calorie intake (20%:35%:45% calories at breakfast, lunch, and dinner)
Number of subjects: 30
Study: 35590308

Group type: COMPARATOR
Intervention: LIA (Local Infiltration Analgesia) with ropivacaine, morphine, and betamethasone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ACB (Adductor Canal Block) combined with LIA (Local Infiltration Analgesia) with ropivacaine, morphine, and betamethasone
Number of subjects: 60
Study: 33478465

Group type: COMPARATOR
Intervention: Financial Incentive (FI) group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Social Network Incentive plus Financial Incentive (SNI + FI) group
Number of subjects: 39
Study: 33172547

Group type: EXPERIMENTAL
Intervention: Hypoglycemia group
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 258
Study: 35172872

Group type: EXPERIMENTAL
Intervention: Needle-knife fistulotomy (NKF)
Number of subjects: 538

Group type: COMPARATOR
Intervention: Standard cannulation
Number of subjects: 538
Study: 34372930

Group type: EXPERIMENTAL
Intervention: Preventative intervention comprising risk communication using an online risk calculator, counselling style adapted from motivational interviewing, and 12 weekly telephone goal reinforcement calls (3 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Verbal lifestyle advice only
Number of subjects: 100
Study: 32563847

Group type: EXPERIMENTAL
Intervention: Higher average proportion days alcohol abstinent
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Higher average heavy drinking
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Alcohol use disorder (AUD)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Time-specific increases in proportion days alcohol abstinent
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Time-specific increases in AUD
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Heavy drinking
Number of subjects: 313
Study: 34872927

Group type: EXPERIMENTAL
Intervention: Three-week language therapy
Number of subjects: 68
Study: 33393711

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 2.5 g EP/kg diet
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 5.0 g EP/kg diet
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 7.5 g EP/kg diet
Number of subjects: 320

Group type: COMPARATOR
Intervention: Basal diet without supplementation (control)
Number of subjects: 320
Study: 35093512

Group type: EXPERIMENTAL
Intervention: Walking meditation (WM)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rubber-band exercise (RE)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 35131532

Group type: EXPERIMENTAL
Intervention: Polycarbophil vaginal (PCV) gel 1 g twice a week for 30 days
Number of subjects: 53

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) vaginal gel 3 g every 3 days for 30 days
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Polycarbophil vaginal (PCV) gel
Number of subjects: 53

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) vaginal gel
Number of subjects: 53
Study: 35010599

Group type: EXPERIMENTAL
Intervention: Risk communication
Number of subjects: 1802

Group type: COMPARATOR
Intervention: No risk communication (Control)
Number of subjects: 1802
Study: 36335780

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 32
Study: 33652160

Group type: EXPERIMENTAL
Intervention: Vaginal isosorbide mononitrate (40 mg, up to 3 doses)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 34913787

Group type: EXPERIMENTAL
Intervention: LY01008
Number of subjects: 112

Group type: COMPARATOR
Intervention: Avastin®
Number of subjects: 112
Study: 33136314

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention on healthy lifestyles, education on self-esteem, pain awareness, communication, and relaxation techniques
Number of subjects: 279

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 279
Study: 32034481

Group type: COMPARATOR
Intervention: Catheter-based renal denervation
Number of subjects: 300
Study: 36074385

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 μg/kg/h)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 34101342

Group type: EXPERIMENTAL
Intervention: Ultrashort implants (5.5 mm)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard-length implants (10 mm)
Number of subjects: 48
Study: 33174614

Group type: EXPERIMENTAL
Intervention: Web-based pain coping skills training (PCST)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 107
Study: 32253688

Group type: EXPERIMENTAL
Intervention: NIRF/ICG
Number of subjects: 196

Group type: COMPARATOR
Intervention: no-NIRF/ICG
Number of subjects: 196
Study: 33160908

Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ibuprofen plus oxycodone
Number of subjects: 70
Study: 32451777

Group type: EXPERIMENTAL
Intervention: Basivertebral nerve (BVN) ablation
Number of subjects: 117
Study: 35758258

Group type: EXPERIMENTAL
Intervention: BMS-986120 75 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: BMS-986120 180 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: BMS-986120 ≥10 mg for 7 days
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: BMS-986120 (various doses)
Number of subjects: 88

Group type: COMPARATOR
Intervention: BMS-986120
Number of subjects: 88
Study: 34408488

Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 32422769

Group type: EXPERIMENTAL
Intervention: Communicability sequence entropy and Jensen-Shannon divergence measure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real networks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized network models
Number of subjects: 0
Study: 35502036

Group type: EXPERIMENTAL
Intervention: Lubricated eyelid speculum
Number of subjects: 130

Group type: COMPARATOR
Intervention: Dry eyelid speculum
Number of subjects: 130
Study: 32794071

Group type: EXPERIMENTAL
Intervention: Peer group eHealth interventions
Number of subjects: 57
Study: 35554022

Group type: EXPERIMENTAL
Intervention: Nomogram based on significant indices (age, tumor type, type of surgery, radiation therapy)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Radiotherapy and surgical resection
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Age and pathological type
Number of subjects: 197
Study: 32449174

Group type: EXPERIMENTAL
Intervention: Ravulizumab (administered every 8 weeks)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Eculizumab (administered every 2 weeks)
Number of subjects: 441
Study: 32606085

Group type: EXPERIMENTAL
Intervention: Cerebral small vessel disease (CSVD)
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Intracranial arterial stenosis (ICAS)
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Six-point modified CSVD score
Number of subjects: 1045

Group type: COMPARATOR
Intervention: Control (no CSVD or ICAS)
Number of subjects: 1045
Study: 35077197

Group type: EXPERIMENTAL
Intervention: Visual Analysis of Swallowing Efficiency and Safety (VASES)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Verbal numerical ratings
Number of subjects: 57
Study: 33229039

Group type: EXPERIMENTAL
Intervention: Polyalkenoic acid conditioning
Number of subjects: 6

Group type: COMPARATOR
Intervention: No conditioning (control)
Number of subjects: 6
Study: 32571399

Group type: EXPERIMENTAL
Intervention: Three hours of uninterrupted sitting
Number of subjects: 22

Group type: COMPARATOR
Intervention: Regular (every 30 min) two-minute walking breaks during sitting
Number of subjects: 22

Group type: COMPARATOR
Intervention: Higher mental activity during sitting
Number of subjects: 22
Study: 36217131

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg, once daily)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (160/4.5 μg, one puff, twice daily)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Montelukast plus budesonide/formoterol
Number of subjects: 99
Study: 33944623

Group type: EXPERIMENTAL
Intervention: DENV-2
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: NS1 positive sera
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: DENV-1
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: DENV-3
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: DENV-4
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: ZIKV
Number of subjects: 639

Group type: COMPARATOR
Intervention: DENV-2, DENV-3, ZIKV
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Aedes aegypti
Number of subjects: 639
Study: 32453453

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure reduction with intravenous nicardipine
Number of subjects: 913
Study: 33685268

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with standard-of-care (SOC)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard-of-care (SOC) only
Number of subjects: 81
Study: 34314516

Group type: EXPERIMENTAL
Intervention: CAPABLE program (10-session, home-based interprofessional program)
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: CAPABLE program (full-tested dose)
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: CAPABLE program (cost analysis)
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: CAPABLE program (decreased dose)
Number of subjects: 1144
Study: 32592516

Group type: EXPERIMENTAL
Intervention: Non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 36051935

Group type: EXPERIMENTAL
Intervention: Mindfulness combined with aerobic exercise (MMAE)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mindfulness meditation (MM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Aerobic exercise (AE)
Number of subjects: 120
Study: 33801485

Group type: COMPARATOR
Intervention: Various lifestyle interventions (diet, activity, sleep, emotion regulation, parenting education)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 29
Study: 34203033

Group type: EXPERIMENTAL
Intervention: Plant-based protein product (FP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 36152686

Group type: EXPERIMENTAL
Intervention: Intermittent positive pressure ventilation via face mask and T piece from 20 to 50 seconds of age with a fractional inspired oxygen of 0.3
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard treatment (gentle stimulation in a neutral position for 50 seconds)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Intervention group (breathing support)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 113
Study: 33637001

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Reboxetine (noradrenaline reuptake inhibitor)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Citalopram and Reboxetine (irrespective of class)
Number of subjects: 601
Study: 34607470

Group type: EXPERIMENTAL
Intervention: Effortful swallowing
Number of subjects: 15
Study: 33875726

Group type: EXPERIMENTAL
Intervention: Percutaneous renal puncture guided by 3D visualization fused with ultrasound
Number of subjects: 118

Group type: COMPARATOR
Intervention: Percutaneous renal puncture guided by B-ultrasonography (B-US)
Number of subjects: 118
Study: 35473648

Group type: EXPERIMENTAL
Intervention: Insomnia Coach (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control (n = 25)
Number of subjects: 50
Study: 32044999

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 35276309

Group type: EXPERIMENTAL
Intervention: Active tDCS (cathodal stimulation over the left DLPFC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 29
Study: 35412211

Group type: EXPERIMENTAL
Intervention: EUS-guided celiac plexus neurolysis (EUS-CPN) plus EUS-guided celiac ganglia neurolysis (EUS-CGN)
Number of subjects: 51

Group type: COMPARATOR
Intervention: EUS-guided celiac plexus neurolysis (EUS-CPN) alone
Number of subjects: 51
Study: 34456565

Group type: EXPERIMENTAL
Intervention: SPSRS application (positive word stimulus in a 10-minute video)
Number of subjects: 32

Group type: COMPARATOR
Intervention: YouTube application (without positive word stimulus in 10-minute video)
Number of subjects: 32
Study: 35766283

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS, 2 mA for 20 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham-tDCS (placebo)
Number of subjects: 8
Study: 34462283

Group type: EXPERIMENTAL
Intervention: Patient decision aid for subacromial decompression surgery and rotator cuff repair surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patient decision aid
Number of subjects: 40
Study: 32442020

Group type: EXPERIMENTAL
Intervention: Dupilumab treatment
Number of subjects: 93
Study: 36410442

Group type: EXPERIMENTAL
Intervention: Native vessel PCI
Number of subjects: 584

Group type: COMPARATOR
Intervention: SVG PCI
Number of subjects: 584
Study: 34433118

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 times/week for 8 weeks at 60 - 70% of VO2max + home exercises)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (home exercises program 3 times a week for 8 weeks)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 38
Study: 32371517

Group type: EXPERIMENTAL
Intervention: Implementation of care managers for patients with depression
Number of subjects: 497
Study: 34989648

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic/resistance 3 times/week, starting at ∼13th gestation week until birth)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Combined groups (exercise and control)
Number of subjects: 80
Study: 33462913

Group type: EXPERIMENTAL
Intervention: Model including families' physical/mental health status and preparedness toward bereavement
Number of subjects: 17312
Study: 32353052

Group type: EXPERIMENTAL
Intervention: Semi-automated measurements of ellipsoid zone (EZ) defect area
Number of subjects: 75

Group type: COMPARATOR
Intervention: Manual measurements of ellipsoid zone (EZ) defect area
Number of subjects: 75

Group type: COMPARATOR
Intervention: Comparison of semi-automated and manual measurements
Number of subjects: 75
Study: 36332823

Group type: EXPERIMENTAL
Intervention: Analog insulin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Human insulin
Number of subjects: 102
Study: 33852173

Group type: EXPERIMENTAL
Intervention: GIP injection
Number of subjects: 11

Group type: COMPARATOR
Intervention: GLP-2 injection
Number of subjects: 11
Study: 35400136

Group type: EXPERIMENTAL
Intervention: Arthroscopic osteochondroplasty
Number of subjects: 214

Group type: COMPARATOR
Intervention: Arthroscopic lavage
Number of subjects: 214
Study: 32091925

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 12647

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 12647
Study: 35868987

Group type: EXPERIMENTAL
Intervention: Cycling at 55 % of maximal aerobic power
Number of subjects: 28

Group type: COMPARATOR
Intervention: Running at 55 % of maximal oxygen uptake
Number of subjects: 28

Group type: COMPARATOR
Intervention: Running
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 28
Study: 34327591

Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood volume (BVdeconv > median)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood volume (BVPatlak > median)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DCE-CT-derived blood flow (BFdeconv > median)
Number of subjects: 25

Group type: COMPARATOR
Intervention: CD34-indexT > median
Number of subjects: 25

Group type: COMPARATOR
Intervention: CD34-indexTN > median
Number of subjects: 25